R Mark Adams Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

R Mark Adams is Chief Operating Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 175,361 shares of ADPT, which is worth approximately $880,312. The most recent transaction as insider was on Apr 11, 2023, when has been sold 2,308 shares (Common Stock) at a price of $8.63 per share, resulting in proceeds of $19,918. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 175K
0% 3M change
0% 12M change
Total Value Held $880,312

R MARK ADAMS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 11 2023
SELL
Open market or private sale
$19,918 $8.63 p/Share
2,308 Reduced 1.3%
175,361 Common Stock
Apr 10 2023
SELL
Open market or private sale
$6,944 $8.5 p/Share
817 Reduced 0.46%
177,669 Common Stock
Mar 07 2023
SELL
Open market or private sale
$147,533 $8.6 p/Share
17,155 Reduced 8.77%
178,486 Common Stock
Mar 06 2023
SELL
Open market or private sale
$55,953 $8.57 p/Share
6,529 Reduced 3.23%
195,641 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
88,652 Added 30.48%
202,170 Common Stock
Jan 10 2023
SELL
Open market or private sale
$18,275 $8.58 p/Share
2,130 Reduced 1.84%
113,518 Common Stock
Jan 09 2023
SELL
Open market or private sale
$8,457 $8.5 p/Share
995 Reduced 0.85%
115,648 Common Stock
Oct 10 2022
SELL
Open market or private sale
$16,285 $7.13 p/Share
2,284 Reduced 1.92%
116,643 Common Stock
Oct 07 2022
SELL
Open market or private sale
$6,400 $7.61 p/Share
841 Reduced 0.7%
118,927 Common Stock
Jul 08 2022
SELL
Open market or private sale
$24,081 $10.47 p/Share
2,300 Reduced 1.88%
119,768 Common Stock
Jul 07 2022
SELL
Open market or private sale
$7,862 $9.53 p/Share
825 Reduced 0.67%
122,068 Common Stock
Apr 07 2022
SELL
Open market or private sale
$10,944 $13.17 p/Share
831 Reduced 0.67%
122,893 Common Stock
Mar 07 2022
SELL
Open market or private sale
$14,940 $12.01 p/Share
1,244 Reduced 1.0%
123,724 Common Stock
Mar 04 2022
BUY
Grant, award, or other acquisition
-
74,135 Added 37.23%
124,968 Common Stock
Jan 07 2022
SELL
Open market or private sale
$23,810 $23.32 p/Share
1,021 Reduced 1.97%
50,833 Common Stock
Oct 08 2021
SELL
Open market or private sale
$60,640 $33.67 p/Share
1,801 Reduced 3.36%
51,854 Common Stock
Oct 07 2021
SELL
Open market or private sale
$42,990 $32.47 p/Share
1,324 Reduced 2.41%
53,655 Common Stock
Jul 08 2021
SELL
Open market or private sale
$81,820 $36.3 p/Share
2,254 Reduced 3.94%
54,979 Common Stock
Jul 07 2021
SELL
Open market or private sale
$34,335 $39.42 p/Share
871 Reduced 1.5%
57,233 Common Stock
Jun 17 2021
SELL
Open market or private sale
$583,320 $40.0 p/Share
14,583 Reduced 20.06%
58,104 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
$409,782 $28.1 p/Share
14,583 Added 16.71%
72,687 Common Stock
Jun 14 2021
SELL
Open market or private sale
$345,596 $38.77 p/Share
8,914 Reduced 13.3%
58,104 Common Stock
Apr 07 2021
SELL
Open market or private sale
$151,831 $42.34 p/Share
3,586 Reduced 5.08%
67,018 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
20,604 Added 22.59%
70,604 Common Stock
RMA

R Mark Adams

Chief Operating Officer
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT